19-LB: Statin Use as a Primary Prevention in Patients with Type 1 Diabetes: Where Do We Stand?

Dalal S.A. Ali; Tomas P. Griffin; Rachel K Crowley; Ronan Canavan

doi:https://doi.org/10.2337/db21-19-lb

doi.org/10.2337/db21-19-lb

19-LB: Statin Use as a Primary Prevention in Patients with Type 1 Diabetes: Where Do We Stand?

Dalal S.A. Ali

1

,

Tomas P. Griffin,

..., Ronan Canavan

Diabetes7.70

Volume: 70, Issue: Supplement_1

Published: Jun 1, 2021

Abstract

Type 1 diabetes (T1D) carries a high cardiovascular risk (CVD). Statins reduce risk of non-fatal myocardial infarction when used as primary prevention in selected patients[1]. We reviewed 205 electronic records of patients with T1D at our center from July 2019 to September 2019. We followed 2018 NICE guidelines for statin use as a primary prevention for our analysis (1)age ≥40 years (2)diabetes duration ≥10 years (3)established nephropathy...